
Frontiers in Pharmacology, Год журнала: 2024, Номер 15
Опубликована: Окт. 1, 2024
β-nicotinamide mononucleotide (NMN) is a naturally occurring biologically active nucleotide widely present in organisms and an inherent substance the human body. As critical intermediate synthesizing coenzyme I (NAD+), it participates multiple biochemical reactions body closely related to immunity, metabolism, other factors. In recent years, NMN has rapidly developed made significant progress medicine, food, healthcare. However, there currently lack of comprehensive reports on research NMN, as well exploration analysis current achievements NMN. Therefore, this review based retrieving relevant from databases at home abroad, with retrieval time database establishment 20 May 2024. Subsequently, literature search, reading, key information extraction, organization, summarization were conducted aim providing in-depth characteristics, metabolic pathways, pharmacological effects, clinical trials, wide applications drug development food applications. Furthermore, offers personal insights into NMN’s potential future developments advancements state existing challenges comprehensively. Ultimately, aims provide guidance serve reference for application, innovation, progression research.
Язык: Английский